Literature DB >> 7396021

Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow.

D D Heistad, M L Marcus, S I Said, P M Gross.   

Abstract

These experiments were performed to determine whether the neurotransmitters acetylcholine (ACh) and vasoactive intestinal peptide (VIP) increase cerebral blood flow (CBF). In anesthetized dogs, infusion of very large doses of ACh (500 microgram/min) into the carotid artery increased CBF (measured with microspheres) 50%. Anatomical limitations prevented adequate testing of cerebrovascular responses in dogs. In anesthetized rabbits, infusion of ACh (10 microgram/min) into the carotid artery produced a twofold increase in CBF. Vessels in gray matter were more responsive than vessels in white matter. ACh did not alter cerebral oxygen consumption, which indicates that the dilator effect of the drug is not an indirect effect mediated through an increase in metabolism. The vasodilator response to ACh was attenuated by atropine (1 mg iv). Intracarotid infusion of VIP in rabbits increased blood flow to cerebral gray matter: infusion of VIP (10 microgram/min) incresed flow 33%. We conclude that 1) cerebral vasodilator responses to ACh and VIP are larger than previously recognized and 2) responses to these drugs occur primarily in cerebral gray matter. Because the neurotransmitters increase CBF significantly, these studies should encourage further studies concerning effects of cholinergic and peptidergic nerves on cerebral vessels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396021     DOI: 10.1152/ajpheart.1980.239.1.H73

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  19 in total

1.  Evidence for in vivo cerebrovascular neurogenic vasodilatation in the rat.

Authors:  N Suzuki; F Gotoh; J Gotoh; A Koto
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

Review 2.  Neuronal control of brain microvessel function.

Authors:  H Kobayashi; M S Magnoni; S Govoni; F Izumi; A Wada; M Trabucchi
Journal:  Experientia       Date:  1985-04-15

Review 3.  Perivascular innervation of the cerebral circulation: involvement in the pathophysiology of subarachnoid hemorrhage.

Authors:  H Hara; L Edvinsson
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

4.  The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats.

Authors:  Jason J McDougall; Ali Kursat Barin
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 5.  Integrative regulation of human brain blood flow.

Authors:  Christopher K Willie; Yu-Chieh Tzeng; Joseph A Fisher; Philip N Ainslie
Journal:  J Physiol       Date:  2014-01-06       Impact factor: 5.182

6.  Immunohistochemical localisation of regulatory neuropeptides in human circumvallate papillae.

Authors:  T Kusakabe; H Matsuda; Y Gono; M Furukawa; H Hiruma; T Kawakami; M Tsukuda; T Takenaka
Journal:  J Anat       Date:  1998-05       Impact factor: 2.610

7.  Adrenalectomy increases local cerebral blood flow in the rat hippocampus.

Authors:  Y Endo; J Nishimura; F Kimura
Journal:  Pflugers Arch       Date:  1994-02       Impact factor: 3.657

8.  Distribution of galanin-immunoreactive nerve fibers in the carotid labyrinth of the bullfrog, Rana catesbeiana: Comparison with substance P-immunoreactive fibers.

Authors:  T Kusakabe; T Kawakami; M Ono; H Hori; H Sawada; T Takenaka
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

9.  Ontogeny of substance P-, CGRP-, and VIP-containing nerve fibers in the amphibian carotid labyrinth of the bullfrog, Rana catesbeiana. An immunohistochemical study.

Authors:  T Kusakabe
Journal:  Cell Tissue Res       Date:  1992-07       Impact factor: 5.249

Review 10.  Regulation of cerebral vasculature in normal and ischemic brain.

Authors:  Tobias Kulik; Yoshikazu Kusano; Shimon Aronhime; Adam L Sandler; H Richard Winn
Journal:  Neuropharmacology       Date:  2008-04-26       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.